Jamison Bryce Tuttle
14Patents
2h-index
51Co-inventors
53Inventor score
Filing activity: Nov 21, 2005 → Apr 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8183238B2 | Bicyclic and tricyclic compounds as KAT II inhibitors | Chemistry; Metallurgy | 3 | Active |
| US8933224B2 | Triazine derivatives | Chemistry; Metallurgy | 3 | Active |
| US9296761B2 | Triazine derivatives | Chemistry; Metallurgy | 1 | Active |
| US12358897B2 | Compounds and method of treating COVID-19 | Chemistry; Metallurgy | 0 | Active |
| US11926642B2 | Compounds and methods for the treatment of COVID-19 | Chemistry; Metallurgy | 0 | Active |
| US11684616B2 | Azalactam compounds as HPK1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11390623B2 | 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands | Human Necessities | 0 | Active |
| US7323604B2 | Hydride reduction of α,β-unsaturated carbonyl compounds using chiral organic catalysts | Chemistry; Metallurgy | 0 | Expired |
| US11541034B2 | Nitrile-containing antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US11351149B2 | Nitrile-containing antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US11142525B2 | Azalactam compounds as HPK1 inhibitors | Human Necessities | 0 | Active |
| US8487104B2 | KAT II inhibitors | Human Necessities | 0 | Active |
| US11452711B2 | Nitrile-containing antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US10590128B2 | 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.